𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Bevacizumab in combination with irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) in patients with metastatic colorectal cancer who were previously treated with oxaliplatin-containing regimens: a multicenter observational cohort study (TCTG 2nd-BV study)

✍ Scribed by Toshikazu Moriwaki, Hideaki Bando, Atsuo Takashima, Kentaro Yamazaki, Taito Esaki, Keishi Yamashita, Mutsumi Fukunaga, Yasuhiro Miyake, Kenji Katsumata, Satoshi Kato, Taroh Satoh, Mitsuharu Ozeki, Eishi Baba, Shigemasa Yoshida, Narikazu Boku, et al

Book ID
118821534
Publisher
Springer US
Year
2011
Tongue
English
Weight
238 KB
Volume
29
Category
Article
ISSN
1357-0560

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Efficacy and safety of bevacizumab-based
Efficacy and safety of bevacizumab-based combination regimens in patients with previously untreated metastatic colorectal cancer: Final results from a randomised phase ii study of bevacizumab plus 5-fluorouracil, leucovorin plus irinotecan versus bevacizumab plus capecitabine plus irinotecan (FNCLCC ACCORD 13/0503 study)
✍ Ducreux, M.; Adenis, A.; Pignon, J.-P.; FranΓ§ois, E.; Chauffert, B.; IchantΓ©, J. πŸ“‚ Article πŸ“… 2013 πŸ› Elsevier Science 🌐 English βš– 602 KB